Thus, at most of the points we examined, the frequencies of these two mutations were paralleled except at the terminal stage when the APL clone harboring the deletion PML-RARA mutation had acquired the p.A216V mutation in the PML region of PML-RARA during ATO therapy. Here, RARA is linked to acute promyelocytic leukemia.